{"transactions":[{"id":2622064,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":136826,"kind":"person","name":"Gilman Sydney A.","position":1,"cik":"0001793016","reported_name":"Gilman Sydney A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Regulatory Affairs"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-30T01:18:27.000Z","date":"2021-07-28","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in sixteen nearly equal quarterly installments over four years."}],"balance_after":25000,"derivative":{"exercise_price":5,"expiration_date":"2031-07-27","underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001235802-21-000094","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580221000094/primary_doc.xml","form_type":"4"}},{"id":3126749,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":136826,"kind":"person","name":"Gilman Sydney A.","position":1,"cik":"0001793016","reported_name":"Gilman Sydney A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Regulatory Affairs"}}],"security":"Stock Option (right to buy)","published_at":"2020-06-02T21:36:08.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in twelve nearly equal quarterly installments commencing on September 1, 2020."}],"balance_after":17500,"derivative":{"exercise_price":4.64,"expiration_date":"2030-05-31","underlying":"Common Shares","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001235802-20-000055","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580220000055/primary_doc.xml","form_type":"4"}},{"id":3380065,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":136826,"kind":"person","name":"Gilman Sydney A.","position":1,"cik":"0001793016","reported_name":"Gilman Sydney A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Regulatory Affairs"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-05T21:13:38.000Z","date":"2019-11-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in twelve nearly equal quarterly installments over three years."}],"balance_after":50000,"derivative":{"exercise_price":4,"expiration_date":"2029-10-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001235802-19-000131","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580219000131/primary_doc.xml","form_type":"4"}}]}